Phase I study of erlotinib and hydroxychloroquine in non-small cell lung cancer

被引：0
|
作者：
Sequist, Lecia, V [1 ]
Sharma, Sreenath, V [1 ]
Supko, Jeffrey G. [1 ]
Neal, Joel W. [1 ]
Fidias, Panos [1 ]
Temel, Jennifer [1 ]
Heist, Suk Rebecca [1 ]
Shaw, Alice T. [1 ]
Engelman, Jeffrey A. [1 ]
Settleman, Jeffrey E. [1 ]
Lynch, Thomas J. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S712 / S713
页数：2
相关论文
共 50 条
  • [1] A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer
    Goldberg, Sarah B.
    Supko, Jeffrey G.
    Neal, Joel W.
    Muzikansky, Alona
    Digumarthy, Subba
    Fidias, Panos
    Temel, Jennifer S.
    Heist, Rebecca S.
    Shaw, Alice T.
    McCarthy, Patricia O.
    Lynch, Thomas J.
    Sharma, Sreenath
    Settleman, Jeffrey E.
    Sequist, Lecia V.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1602 - 1608
  • [2] Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer
    O'Mahar, Shannon E.
    Campbell, Toby C.
    Tien Hoang
    Seo, Songwon
    Kim, KyungMann
    Larson, Martha M.
    Marcotte, Sarah M.
    LoConte, Noelle K.
    Traynor, Anne M.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) : 951 - 953
  • [3] A Phase I/II Study Combining Erlotinib andDasatinib for Non-Small Cell Lung Cancer
    Gold, Kathryn A.
    Lee, J. Jack
    Harun, Nusrat
    Tang, Ximing
    Price, Justina
    Kawedia, Jitesh D.
    Tran, Hai T.
    Erasmus, Jeremy J.
    Blumenschein, George R.
    William, Awilliam N.
    Wistuba, Ignacio I.
    Johnson, Faye M.
    ONCOLOGIST, 2014, 19 (10): : 1040 - 1041
  • [4] A phase I/II study combining dasatinib (D) and erlotinib (E) in non-small cell lung cancer
    Johnson, Faye M.
    Tang, XiMing
    Tran, Hai T.
    Mc Intyre, Chelsey
    Price, Justina
    Lee, J. Jack
    Harun, Nusrat
    Wistuba, Ignacio Ivan
    Gold, Kathryn A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Erlotinib in non-small cell lung cancer: a review
    Blackhall, FH
    Rehman, S
    Thatcher, N
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 995 - 1002
  • [6] Erlotinib in the treatment of non-small cell lung cancer
    Brown, Ewan R.
    Shepherd, Frances A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 767 - 775
  • [7] Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
    Stathopoulos, G. P.
    Trafalis, D.
    Dimitroulis, J.
    Athanasiou, A.
    Koutantos, J.
    Anagnostopoulos, A.
    ONCOLOGY LETTERS, 2010, 1 (02) : 335 - 338
  • [8] Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung Cancer
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Nukiwa, Toshihiro
    Mori, Kiyoshi
    Tsuboi, Masahiro
    Horai, Takeshi
    Masuda, Noriyuki
    Eguchi, Kenji
    Mitsudomi, Tetsuya
    Yokota, Soichiro
    Segawa, Yoshihiko
    Ichinose, Yukito
    Fukuoka, Masahiro
    Saijo, Nagahiro
    ANTICANCER RESEARCH, 2010, 30 (02) : 557 - 563
  • [9] Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
    Gerber, David E.
    Boothman, David A.
    Fattah, Farjana J.
    Dong, Ying
    Zhu, Hong
    Skelton, Rachel A.
    Priddy, Laurin L.
    Vo, Peggy
    Dowell, Jonathan E.
    Sarode, Venetia
    Leff, Richard
    Meek, Claudia
    Xie, Yang
    Schiller, Joan H.
    LUNG CANCER, 2015, 90 (03) : 534 - 541
  • [10] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study
    Giaccone, Giuseppe
    Ruiz, Marielle Gallegos
    Le Chevalier, Thierry
    Thatcher, Nick
    Smit, Egbert
    Rodriguez, Jose Antonio
    Janne, Pasi
    Oulid-Aissa, Dalila
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6049 - 6055
12345